Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,026.30
-14.60 (-1.40%)
At close: Feb 12, 2026
Bharat Parenterals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 3,498 | 3,404 | 2,612 | 2,180 | 2,120 | 2,046 |
Other Revenue | -0 | - | 0 | 13.22 | 3.17 | 25.8 |
| 3,498 | 3,404 | 2,612 | 2,193 | 2,123 | 2,072 | |
Revenue Growth (YoY) | 14.21% | 30.31% | 19.11% | 3.28% | 2.46% | -10.99% |
Cost of Revenue | 1,912 | 1,895 | 1,614 | 1,394 | 1,379 | 1,358 |
Gross Profit | 1,586 | 1,508 | 998.57 | 799.43 | 744.1 | 714.06 |
Selling, General & Admin | 685.1 | 512.14 | 245.37 | 187.63 | 159.33 | 153.81 |
Other Operating Expenses | 699.97 | 954.62 | 480.31 | 354.64 | 273.18 | 285.1 |
Operating Expenses | 1,727 | 1,820 | 815.88 | 601.1 | 499.11 | 499.2 |
Operating Income | -140.89 | -311.49 | 182.69 | 198.33 | 244.99 | 214.86 |
Interest Expense | -125.98 | -119.17 | -31.81 | -21.86 | -9.67 | -3.94 |
Interest & Investment Income | 37.96 | 37.96 | 4.97 | 3.38 | 16.76 | 3.55 |
Currency Exchange Gain (Loss) | 61.9 | 61.9 | 33.3 | 46.99 | 13.89 | 6.09 |
Other Non Operating Income (Expenses) | -38.48 | -0.72 | -1.17 | 6.12 | 13.87 | 45.48 |
EBT Excluding Unusual Items | -205.49 | -331.52 | 187.98 | 232.96 | 279.84 | 266.04 |
Gain (Loss) on Sale of Investments | - | - | -0.44 | 3.43 | 11.25 | 5.13 |
Gain (Loss) on Sale of Assets | -9.76 | -9.76 | -0.4 | -0.91 | -7.4 | 0.09 |
Pretax Income | -213.48 | -339.51 | 187.22 | 235.47 | 283.69 | 271.25 |
Income Tax Expense | 72.3 | 97.25 | 82.07 | 78.32 | 70.65 | 68.08 |
Earnings From Continuing Operations | -285.77 | -436.75 | 105.14 | 157.15 | 213.04 | 203.16 |
Minority Interest in Earnings | 204.64 | 310.49 | 40.03 | - | - | 0.73 |
Net Income | -81.13 | -126.26 | 145.17 | 157.15 | 213.04 | 203.89 |
Net Income to Common | -81.13 | -126.26 | 145.17 | 157.15 | 213.04 | 203.89 |
Net Income Growth | - | - | -7.62% | -26.24% | 4.49% | -15.55% |
Shares Outstanding (Basic) | 6 | 7 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 7 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | - | 12.58% | 0.82% | 0.60% | 0.19% | - |
EPS (Basic) | -12.83 | -19.26 | 24.94 | 27.21 | 37.11 | 35.59 |
EPS (Diluted) | -12.83 | -19.26 | 24.94 | 27.21 | 37.11 | 35.59 |
EPS Growth | - | - | -8.37% | -26.67% | 4.29% | -15.55% |
Free Cash Flow | - | -563.3 | -1,090 | -699.37 | -268.38 | 236.07 |
Free Cash Flow Per Share | - | -85.95 | -187.24 | -121.11 | -46.75 | 41.20 |
Dividend Per Share | - | 1.000 | 1.000 | 0.750 | - | - |
Dividend Growth | - | - | 33.33% | - | - | - |
Gross Margin | 45.33% | 44.32% | 38.23% | 36.45% | 35.04% | 34.46% |
Operating Margin | -4.03% | -9.15% | 6.99% | 9.04% | 11.54% | 10.37% |
Profit Margin | -2.32% | -3.71% | 5.56% | 7.17% | 10.03% | 9.84% |
Free Cash Flow Margin | - | -16.55% | -41.73% | -31.89% | -12.64% | 11.39% |
EBITDA | 409.58 | 41.73 | 272.89 | 257.15 | 311.6 | 275.15 |
EBITDA Margin | 11.71% | 1.23% | 10.45% | 11.73% | 14.67% | 13.28% |
D&A For EBITDA | 550.48 | 353.22 | 90.21 | 58.82 | 66.61 | 60.29 |
EBIT | -140.89 | -311.49 | 182.69 | 198.33 | 244.99 | 214.86 |
EBIT Margin | -4.03% | -9.15% | 6.99% | 9.04% | 11.54% | 10.37% |
Effective Tax Rate | - | - | 43.84% | 33.26% | 24.90% | 25.10% |
Revenue as Reported | 3,576 | 3,520 | 2,659 | 2,297 | 2,198 | 2,133 |
Advertising Expenses | - | 15.51 | 17.5 | 7.67 | 6.23 | 5.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.